Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show all 32 disclosures

REDUCEDT+30
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−16,605 sh · $1.5M
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−2,100 sh · $194.7K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
−600 sh · $53.4K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−2,600 sh · $243.0K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDStale
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
−200 sh · $17.8K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
+400 sh · $5.8K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
+7,500 sh · $108.8K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Turtle Cameron
Spyre Therapeutics Inc · NASDAQ
−400 sh · $35.6K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
+27,999 sh · $406.0K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
−18,232 sh · $1.6M
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
−2,016 sh · $177.5K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−16,548 sh · $1.4M
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
−4,384 sh · $381.9K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Burrows Scott L
Spyre Therapeutics Inc · NASDAQ
−900 sh · $77.6K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−6,206 sh · $547.2K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Turtle Cameron
Spyre Therapeutics Inc · NASDAQ
−2,500 sh · $215.9K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Turtle Cameron
Spyre Therapeutics Inc · NASDAQ
−3,700 sh · $325.8K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−400 sh · $35.8K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Turtle Cameron
Spyre Therapeutics Inc · NASDAQ
−8,400 sh · $732.1K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−4,845 sh · $418.6K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
King-Jones Heidy
Spyre Therapeutics Inc · NASDAQ
−400 sh · $36.0K
Filed 3 Sept 2026SEC Form 4view source
DISCLOSEDStale
BlackRock
Spyre Therapeutics Inc · NASDAQ
2,403,441 sh · $56.5M
Filed 30 Jun 2024SEC 13Fview source